NDC 80425-0319-01 - Doxycycline Monohydrate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0319
- Requested NDC
- 80425-0319-01
- Package NDCs from labels
- 80425-0319-1, 80425-0319-2, 80425-0319-3, 80425-0319-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Doxycycline Monohydrate - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0319-1 | Doxycycline Monohydrate | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 2 | |
| 80425-0319-2 | Doxycycline Monohydrate | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | 2 | |
| 80425-0319-3 | Doxycycline Monohydrate | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0319 | DOXYCYCLINE MONOHYDRATE TABLET, FILM COATED [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 2 | Current NDC, 3 package rows | 20250102_f91373f2-c57b-f1f1-e053-6294a90a7bdd.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0319-1 | EA - Each | 80425-0319 | 53712a91-cb71-46d1-a82c-119676c6c0b4 | 1 | 2023-06-06 |
| 80425-0319-2 | EA - Each | 80425-0319 | 9cb3c160-804c-484d-b94e-9355ce488b1e | 1 | 2023-06-06 |
| 80425-0319-3 | EA - Each | 80425-0319 | 42cc8700-1bec-4803-b909-c7ebd8697643 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DOXYCYCLINE | DOXYCYCLINE | Northwind Health Company, LLC | f3319f4f-b535-da12-e053-2995a90ac00f | 2026-01-01 | Warnings, Adverse reactions | N12000U13O |
| Doxycycline | DOXYCYCLINE | Chartwell RX, LLC | 5bebf320-1395-43b9-9404-fe479d70b240 | 2025-12-09 | Warnings, Adverse reactions | 1652673 1650142 N12000U13O |
| Doxycycline | DOXYCYCLINE | Strides Pharma Science Limited | 3b9888a2-ca16-43f7-ab6d-f03188ec2c0d | 2025-12-02 | Warnings, Adverse reactions | 1650444 1652673 1649429 1650142 N12000U13O |
| DOXYCYCLINE | DOXYCYCLINE | Lupin Pharmaceuticals, Inc. | e0e80435-1b6a-4361-8c8a-e432f8f23a1b | 2025-10-23 | Warnings, Adverse reactions | N12000U13O |
| Doxycycline | DOXYCYCLINE | Solco Healthcare US,LLC | 99305d9a-d058-45d6-8dec-19308b1fc5a9 | 2025-09-30 | Warnings, Adverse reactions | N12000U13O |
| doxycycline | DOXYCYCLINE | Chartwell Governmental & Specialty RX, LLC | b8486639-7eb9-4610-9cd4-0e922045d592 | 2025-09-30 | Warnings, Adverse reactions | N12000U13O |
| Doxycycline | DOXYCYCLINE | Strides Pharma Science Limited | d27c58a1-5c99-4007-9bc6-ad9b6fb56db8 | 2025-09-03 | Warnings, Adverse reactions | N12000U13O |
| Doxycycline | DOXYCYCLINE | AvKARE | 3dd8c11c-aa52-9e22-e063-6294a90a5cbd | 2025-09-02 | Warnings, Adverse reactions | N12000U13O |
| DOXYCYCLINE | DOXYCYCLINE | Proficient Rx LP | 00ea3641-18da-4a6f-a779-e16075464d2b | 2025-09-01 | Warnings, Adverse reactions | N12000U13O |
| Doxycycline Monohydrate | DOXYCYCLINE MONOHYDRATE | Chartwell RX, LLC. | 02aa8731-d40f-43d8-8b63-a79a0503f8db | 2025-07-25 | Warnings, Adverse reactions | N12000U13O |
| Doxycycline | DOXYCYCLINE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2bcde264-5f6f-47f6-ae2e-1b7010deacf7 | 2025-07-18 | Warnings, Adverse reactions | 1650444 1652673 1649429 1650142 N12000U13O |
| DOXYCYCLINE | DOXYCYCLINE | Alembic Pharmaceuticals Inc. | a50e953d-447b-4b66-b567-04586174d3f9 | 2025-06-16 | Warnings, Adverse reactions | N12000U13O |
| doxycycline | DOXYCYCLINE | Macleods Pharmaceuticals Limited | 10aca485-850b-4c82-bb7e-5fac2d7a62ce | 2025-06-07 | Warnings, Adverse reactions | N12000U13O |
| Doxycycline | DOXYCYCLINE | Dr.Reddys Laboratories Inc | 7a28cce1-4805-b3d1-4484-e7a49c597660 | 2025-06-06 | Warnings, Adverse reactions | N12000U13O |
| DOXYCYCLINE | DOXYCYCLINE | Lupin Pharmaceuticals, Inc. | 81c5a7fc-3fe0-40b2-bae0-c79eb0b27697 | 2025-06-04 | Warnings, Adverse reactions | N12000U13O |
| Doxycycline | DOXYCYCLINE | Bryant Ranch Prepack | b46208a2-5072-4df5-b2af-379f865545d2 | 2025-06-02 | Warnings, Adverse reactions | ANDA209582 1650142 N12000U13O |
| Doxycycline | DOXYCYCLINE | A-S Medication Solutions | 2b3b3c48-eb60-400c-bdfe-50635a136c90 | 2025-05-28 | Warnings, Adverse reactions | 1650142 N12000U13O |
| doxycycline | DOXYCYCLINE | Zydus Pharmaceuticals USA Inc. | fef9580d-8850-4cbb-89eb-2b4d40ee59c9 | 2025-04-26 | Warnings, Adverse reactions | N12000U13O |
| Doxycycline | DOXYCYCLINE | Sun Pharmaceutical Industries, Inc. | 829dbd3d-5c2b-47b8-96a5-423af78c93b9 | 2025-04-24 | Warnings, Adverse reactions | N12000U13O |
| ORACEA | DOXYCYCLINE | Galderma Laboratories, L.P. | aa15c93a-ff4c-447a-8a21-96da506d8997 | 2025-04-16 | Warnings, Adverse reactions | N12000U13O |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.